Clinical Trial Update: Aliskiren on Retinal Vasculature Treatment Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for aliskiren addressing retinal vasculature in arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Arterial Hypertension | Phase 3 | Status: COMPLETED